Pliant Therapeutics Overview

  • Founded
  • 2016
Founded
  • Status
  • Public
  • Employees
  • 68
Employees
  • Stock Symbol
  • PLRX
Stock Symbol
  • Share Price
  • $31.51
  • (As of Friday Closing)

Pliant Therapeutics General Information

Description

Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 260 Littlefield Avenue
  • San Francisco, CA 94080
  • United States
+1 (650) 000-0000

Pliant Therapeutics Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pliant Therapeutics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$31.51 $32.14 $19.43 - $43.92 $1.12B 35.5M 119K $0.75

Pliant Therapeutics Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 490,743
Revenue 94,404 57,052 0
EBITDA 20,119 (334) (30,298)
Net Income 19,663 (631) (30,276)
Total Assets 312,324 119,064 66,529
Total Debt 384 444 525
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Pliant Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pliant Therapeutics‘s full profile, request access.

Request a free trial

Pliant Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Pliant Therapeutics‘s full profile, request access.

Request a free trial

Pliant Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therap
Biotechnology
San Francisco, CA
68 As of 2020
00000
000000000 00000

00000 00

a commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu
0000000000000
Waltham, MA
00 As of 0000
000.00
000000 - 000 000.00

00000000

magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex
0000 000000000
Atlanta, GA
00 As of 0000
000.00
0000 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pliant Therapeutics Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Eloxx Pharmaceuticals Formerly VC-backed Waltham, MA 00 000.00 000000 - 000 000.00
000000000 Venture Capital-Backed Atlanta, GA 00 000.00 00000000000 000.00
00000000 000000000 Corporation Norcross, GA 0 000000000000
0000000 Venture Capital-Backed Groningen, Netherlands 0 00000 0000000000 0 00000
000000 00000000000 Formerly PE-Backed New York, NY 000 00000 000000000 - 00000
You’re viewing 5 of 16 competitors. Get the full list »

Pliant Therapeutics Executive Team (15)

Name Title Board Seat Contact Info
Bernard Coulie MD Chief Executive Officer & Board Member
Keith Cummings MD Chief Financial Officer, Finance
Hans Hull JD Chief Business Officer
Éric Lefebvre MD Chief Medical Officer
Barbara Howes Executive
You’re viewing 5 of 15 executive team members. Get the full list »

Pliant Therapeutics Board Members (12)

Name Representing Role Since
Bernard Coulie MD Pliant Therapeutics Chief Executive Officer & Board Member 000 0000
Charles Homcy MD Third Rock Ventures Board Member 000 0000
David Pyott Self Board Member 000 0000
Gayle Crowell Self Board Member 000 0000
Hoyoung Huh Ph.D Self Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Pliant Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pliant Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pliant Therapeutics‘s full profile, request access.

Request a free trial